These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23111735)

  • 1. A proteomic study of potential VEGF-C-associated proteins in bladder cancer T24 cells.
    Zhang HH; Qi F; Zu XB; Cao YH; Miao JG; Xu L; Qi L
    Med Sci Monit; 2012 Nov; 18(11):BR441-9. PubMed ID: 23111735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA interference-mediated vascular endothelial growth factor-C reduction suppresses malignant progression and enhances mitomycin C sensitivity of bladder cancer T24 cells.
    Zhang HH; Qi F; Shi YR; Miao JG; Zhou M; He W; Chen MF; Li Y; Zu XB; Qi L
    Cancer Biother Radiopharm; 2012 Jun; 27(5):291-8. PubMed ID: 21902544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-101 suppresses vascular endothelial growth factor C that inhibits migration and invasion and enhances cisplatin chemosensitivity of bladder cancer cells.
    Lei Y; Li B; Tong S; Qi L; Hu X; Cui Y; Li Z; He W; Zu X; Wang Z; Chen M
    PLoS One; 2015; 10(2):e0117809. PubMed ID: 25658842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implication of vascular endothelial growth factor A and C in revealing diagnostic lymphangiogenic markers in node-positive bladder cancer.
    Poyet C; Thomas L; Benoit TM; Delmo DA; Luberto L; Banzola I; Günthart MS; Sais G; Eberli D; Sulser T; Provenzano M
    Oncotarget; 2017 Mar; 8(13):21871-21883. PubMed ID: 28423532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VEGF-C inhibition reverses resistance of bladder cancer cells to cisplatin via upregulating maspin.
    Zhu H; Yun F; Shi X; Wang D
    Mol Med Rep; 2015 Aug; 12(2):3163-9. PubMed ID: 25936422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of secreted proteins for the study of bladder cancer cell aggressiveness.
    Makridakis M; Roubelakis MG; Bitsika V; Dimuccio V; Samiotaki M; Kossida S; Panayotou G; Coleman J; Candiano G; Anagnou NP; Vlahou A
    J Proteome Res; 2010 Jun; 9(6):3243-59. PubMed ID: 20423150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting MACC1 by RNA interference inhibits proliferation and invasion of bladder urothelial carcinoma in T24 cells.
    Xu ST; Ding X; Ni QF; Jin SJ
    Int J Clin Exp Pathol; 2015; 8(7):7937-44. PubMed ID: 26339359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein expression profile related to cisplatin resistance in bladder cancer cell lines detected by two-dimensional gel electrophoresis.
    Taoka Y; Matsumoto K; Ohashi K; Minamida S; Hagiwara M; Nagi S; Saito T; Kodera Y; Iwamura M
    Biomed Res; 2015; 36(4):253-61. PubMed ID: 26299484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of differentially-expressed proteins between early submucosal non-invasive and invasive colorectal cancer using 2D-DIGE and mass spectrometry.
    Zhang J; Song MQ; Zhu JS; Zhou Z; Xu ZP; Chen WX; Chen NW
    Int J Immunopathol Pharmacol; 2011; 24(4):849-59. PubMed ID: 22230392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential proteomic analysis of nuclear matrix in muscle-invasive bladder cancer: potential to improve diagnosis and prognosis.
    Barboro P; Rubagotti A; Orecchia P; Spina B; Truini M; Repaci E; Carmignani G; Romagnoli A; Introini C; Boccardo F; Carnemolla B; Balbi C
    Cell Oncol; 2008; 30(1):13-26. PubMed ID: 18219107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma.
    Guo B; Zhang Y; Luo G; Li L; Zhang J
    Anat Rec (Hoboken); 2009 May; 292(5):633-9. PubMed ID: 19382240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of proteins differentially expressed in adriamycin-resistant (pumc-91/ADM) and parental (pumc-91) human bladder cancer cell lines by proteome analysis.
    Meng Q; Lei T; Zhang M; Zhao J; Zhao XH; Zhang M
    J Cancer Res Clin Oncol; 2013 Mar; 139(3):509-19. PubMed ID: 23183654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does phosphorylation of cofilin affect the progression of human bladder cancer?
    Chung H; Kim B; Jung SH; Won KJ; Jiang X; Lee CK; Lim SD; Yang SK; Song KH; Kim HS
    BMC Cancer; 2013 Feb; 13():45. PubMed ID: 23374291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomics analysis of bladder cancer exosomes.
    Welton JL; Khanna S; Giles PJ; Brennan P; Brewis IA; Staffurth J; Mason MD; Clayton A
    Mol Cell Proteomics; 2010 Jun; 9(6):1324-38. PubMed ID: 20224111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble vascular endothelial growth factor receptor-3 suppresses lymphangiogenesis and lymphatic metastasis in bladder cancer.
    Yang H; Kim C; Kim MJ; Schwendener RA; Alitalo K; Heston W; Kim I; Kim WJ; Koh GY
    Mol Cancer; 2011 Apr; 10():36. PubMed ID: 21481239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD147 overexpression is a prognostic factor and a potential therapeutic target in bladder cancer.
    Xue YJ; Lu Q; Sun ZX
    Med Oncol; 2011 Dec; 28(4):1363-72. PubMed ID: 20509007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
    Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
    Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA interference suppressing PLCE1 gene expression decreases invasive power of human bladder cancer T24 cell line.
    Ou L; Guo Y; Luo C; Wu X; Zhao Y; Cai X
    Cancer Genet Cytogenet; 2010 Jul; 200(2):110-9. PubMed ID: 20620593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibition of bladder cancer cell growth and angiogenesis by co-blockage of vascular endothelial growth factor and its receptor KDR].
    Chen XL; Liu LC; Xu ZG; Li Z; Li RW; Gao RJ; Wang S; Zhang M; Guo H
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):578-82. PubMed ID: 19102933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short interfering RNA directed against Slug blocks tumor growth, metastasis formation, and vascular leakage in bladder cancer.
    Wang X; Zhang K; Sun L; Liu J; Lu H
    Med Oncol; 2011 Dec; 28 Suppl 1():S413-22. PubMed ID: 21053100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.